What do systematic reviews say?

Short‐acting insulin analogues vs regular human insulin

The review found no eligible studies for this question.

• Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found